| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 472,1 k € | -6.6% | 505,4 k € | +118.5% | 231,3 k € | +248.0% | -156,2 k € | -193.1% | 167,9 k € | -12.2% | 191,2 k € | -23.4% | 249,5 k € | -10.6% | 279,0 k € | -0.3% | 279,8 k € | -17.1% | 337,6 k € | +10.7% | 304,8 k € | -10.7% | 341,3 k € | -54.7% | 753,8 k € | +92.2% | 392,2 k € | -3.4% | 405,8 k € | -19.9% | 506,6 k € | +250.8% | 144,4 k € | -34.4% | 220,0 k € | +14.6% | 192,0 k € | -30.8% | 277,4 k € | |
| EBITDA | 340,6 k € | -1.6% | 346,0 k € | +140.7% | 143,7 k € | +167.0% | -214,4 k € | -385.2% | 75,2 k € | -32.3% | 111,0 k € | +24.2% | 89,3 k € | -34.1% | 135,4 k € | +28.0% | 105,8 k € | -26.2% | 143,2 k € | +2.9% | 139,3 k € | +25.5% | 111,0 k € | -75.8% | 457,9 k € | +326.3% | 107,4 k € | -12.0% | 122,0 k € | -32.1% | 179,7 k € | +396.8% | 36,2 k € | -62.0% | 95,1 k € | +133.2% | 40,8 k € | -69.2% | 132,4 k € | |
| Operating profit | 60,2 k € | -75.8% | 248,5 k € | +181.4% | 88,3 k € | +136.0% | 37,4 k € | -14.5% | 43,8 k € | +169.1% | -63,3 k € | -206.6% | 59,4 k € | -3.8% | 61,8 k € | +72.4% | 35,8 k € | -29.1% | 50,5 k € | +0.5% | 50,3 k € | +78.0% | 28,2 k € | -91.5% | 331,6 k € | +1315.1% | 23,4 k € | -55.6% | 52,8 k € | +155.3% | 20,7 k € | +51.8% | 13,6 k € | -68.2% | 42,8 k € | +149.2% | 17,2 k € | -49.9% | 34,3 k € | |
| Profit/loss | 28,2 k € | -72.6% | 103,0 k € | +1154368.4% | 8,9 € | -99.9% | 10,9 k € | +0.5% | 10,8 k € | +110.8% | -100,0 k € | -4767.4% | 2,1 k € | -72.4% | 7,8 k € | +2114.3% | -385,6 € | -108.2% | 4,7 k € | +303.7% | 1,2 k € | -27.9% | 1,6 k € | -99.4% | 286,5 k € | +1925.5% | -15,7 k € | -1093.7% | 1,6 k € | +120.4% | -7,7 k € | -1391.0% | 599,1 € | -60.5% | 1,5 k € | +14.0% | 1,3 k € | -40.4% | 2,2 k € | |
| Equity | 118,0 k € | +31.5% | 89,7 k € | +776.7% | -13,3 k € | +0.1% | -13,3 k € | +45.0% | -24,1 k € | +30.9% | -34,9 k € | -153.7% | 65,1 k € | +3.4% | 62,9 k € | +14.1% | 55,1 k € | -0.7% | 55,5 k € | +9.2% | 50,9 k € | +2.3% | 49,7 k € | +3.3% | 48,1 k € | +1.0% | 47,6 k € | -24.8% | 63,3 k € | +2.6% | 61,7 k € | -11.1% | 69,5 k € | +0.9% | 68,9 k € | +2.3% | 67,4 k € | +2.0% | 66,0 k € | |
| Total assets | 3,2 M € | +14.8% | 2,8 M € | +19.2% | 2,4 M € | +21.9% | 1,9 M € | +14.8% | 1,7 M € | +5.3% | 1,6 M € | +6.9% | 1,5 M € | +5.0% | 1,4 M € | -6.9% | 1,5 M € | +6.5% | 1,4 M € | +9.7% | 1,3 M € | +12.5% | 1,2 M € | -6.2% | 1,2 M € | -6.5% | 1,3 M € | +24.5% | 1,1 M € | -16.8% | 1,3 M € | -5.8% | 1,4 M € | -61.9% | 3,6 M € | +33.3% | 2,7 M € | +15.8% | 2,3 M € | |
| Cash | 27,3 k € | +253.9% | 7,7 k € | -35.1% | 11,9 k € | +256.1% | 3,3 k € | -48.0% | 6,4 k € | +47.7% | 4,3 k € | +91.0% | 2,3 k € | -38.8% | 3,7 k € | +388.2% | 762,1 € | -68.6% | 2,4 k € | +86.8% | 1,3 k € | -91.3% | 14,9 k € | +45.9% | 10,2 k € | +12.3% | 9,1 k € | -10.7% | 10,2 k € | -74.1% | 39,3 k € | -47.4% | 74,6 k € | -69.8% | 247,3 k € | +14.8% | 215,4 k € | -23.5% | 281,6 k € | |
| Debts | 3,1 M € | +14.2% | 2,7 M € | +14.8% | 2,4 M € | +21.7% | 2,0 M € | +13.9% | 1,7 M € | +4.6% | 1,6 M € | +14.5% | 1,4 M € | +5.1% | 1,4 M € | -7.6% | 1,5 M € | +6.8% | 1,4 M € | +9.6% | 1,3 M € | +13.1% | 1,1 M € | -6.7% | 1,2 M € | -6.8% | 1,3 M € | +27.7% | 1,0 M € | -18.0% | 1,2 M € | -5.1% | 1,3 M € | -62.9% | 3,5 M € | +36.0% | 2,6 M € | +15.9% | 2,2 M € | |
| Staff | 2,1 | 2,4 | 1,2 | 0,8 | 0,8 | 1,1 | 1,8 | 1,8 | 2,3 | 2,8 | 2,4 | 3,7 | 6,1 | 5,8 | 6 | 5,2 | 1,6 | 2,7 | 3,2 | 3 | ||||||||||||||||||||
Public limited company · Leuven · incorporated on 22/11/2000 · 2,1 ETP
Public limited company profitable and well capitalised. Cash position rising (+253.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
EUROMEDIX POINT OF CARE is a Public limited company incorporated in 2000. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Leuven. It employs on average 2,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette